| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |